Skip to main content
logo
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
207.68
+1.04 (0.50%)
At close: Oct 5, 2026, 4:00 PM EDT
210.00
+2.32 (1.12%)
Pre-market: Oct 6, 2026, 8:42 AM EDT

Revolution Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
44,51315,3988,0834,7202,1151,855
Market Cap Growth
409.79%90.50%71.26%123.15%14.03%-29.43%
Enterprise Value
41,76613,8816,6203,9691,5251,278
Last Close Price
207.6879.6543.7428.6823.8225.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---407.5859.7863.11
PB Ratio
17.079.443.572.583.093.08
P/TBV Ratio
17.559.873.682.693.463.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---342.7843.1143.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.460.260.060.050.090.11
Net Debt / Equity Ratio
-1.05-0.98-0.95-0.97-0.85-0.85
Net Debt / EBITDA Ratio
1.701.363.153.752.282.76
Net Debt / FCF Ratio
2.231.753.794.932.473.32
Asset Turnover
---0.010.050.05
Quick Ratio
11.126.9813.9712.8910.489.66
Current Ratio
11.387.1514.2013.0610.659.77
Return on Equity (ROE)
-79.09%-58.07%-29.33%-34.75%-38.63%-34.73%
Return on Assets (ROA)
-30.12%-30.08%-18.66%-20.71%-20.83%-18.00%
Return on Capital Employed (ROCE)
-41.00%-57.30%-28.80%-24.80%-34.40%-27.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.97%-7.35%-7.42%-9.25%-11.76%-10.09%
FCF Yield
-2.77%-5.93%-7.02%-7.59%-11.12%-8.29%
Buyback Yield / Dilution
-10.45%-13.35%-48.24%-40.34%-10.74%-32.68%
SEC Filings: 10-K · 10-Q